This was clearly stated in a previous document on the use of GnRHa in children (59), and is keeping with a classical observation (based on the LH response to GnRH in the LH-RIA era), that CPP in girls develops along a continuous spectrum of clinical and hormonal changes (60). The gene discussed is PLOD1; the disease is central precocious puberty.